Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 Jul 22;17(7):e1009691. doi: 10.1371/journal.pgen.1009691

Induction of a chromatin boundary in vivo upon insertion of a TAD border

Andréa Willemin 1,‡,¤a, Lucille Lopez-Delisle 2,, Christopher Chase Bolt 2, Marie-Laure Gadolini 1, Denis Duboule 1,2,3,‡,*, Eddie Rodriguez-Carballo 1,‡,¤b,*
Editor: Stefan Mundlos4
PMCID: PMC8330945  PMID: 34292939

Abstract

Mammalian genomes are partitioned into sub-megabase to megabase-sized units of preferential interactions called topologically associating domains or TADs, which are likely important for the proper implementation of gene regulatory processes. These domains provide structural scaffolds for distant cis regulatory elements to interact with their target genes within the three-dimensional nuclear space and architectural proteins such as CTCF as well as the cohesin complex participate in the formation of the boundaries between them. However, the importance of the genomic context in providing a given DNA sequence the capacity to act as a boundary element remains to be fully investigated. To address this question, we randomly relocated a topological boundary functionally associated with the mouse HoxD gene cluster and show that it can indeed act similarly outside its initial genomic context. In particular, the relocated DNA segment recruited the required architectural proteins and induced a significant depletion of contacts between genomic regions located across the integration site. The host chromatin landscape was re-organized, with the splitting of the TAD wherein the boundary had integrated. These results provide evidence that topological boundaries can function independently of their site of origin, under physiological conditions during mouse development.

Author summary

During development, enhancer sequences tightly regulate the spatio-temporal expression of target genes often located hundreds of kilobases away. This complex process is made possible by the folding of chromatin into domains, which are separated from one another by specific genomic regions referred to as boundaries. In order to understand whether such boundary sequences require their particular genomic contexts to achieve their isolating effect, we analyzed the impact of introducing one such boundary, taken from the HoxD locus, into a distinct topological domain. We show that this ectopic boundary splits the host domain into two sub-domains and affects the expression levels of a neighboring gene. We conclude that this sequence can work independently from its genomic context and thus carries all the information necessary to act as a boundary element.

Introduction

Inside the cell nucleus, mammalian genomes are organized at various levels or resolution, from the nucleosomal scale to chromosome territories [1]. At the intermediate level, the use of whole-genome chromosome conformation capture techniques (such as Hi-C) in interphase cells identified sub-megabase to megabase (Mb) structures referred to as topologically associating domains (TADs). These domains appear as discrete on-diagonal pyramid shapes in Hi-C maps, reflecting a high frequency of internal interactions, which seemingly participate in enhancer-promoter communication [2,3]. The limits between TADs are usually referred to as boundaries (or borders) and display variable strengths in terms of contact blockage, often expressed as their insulation score [4]. In the vast majority of cases, TAD boundaries host binding sites for CTCF and they are associated with other features including housekeeping genes and CpG islands [2,5,6].

In vertebrates, the CTCF protein and the cohesin complex participate in DNA interactions, likely through a loop extrusion mechanism: once loaded onto the DNA, the cohesin complex extrudes chromatin, a process stabilized or stalled whenever the cohesin complex encounters bound CTCF sites, preferentially of convergent orientation, or when two loops collide [7,8]. Although the depletion of these proteins or some of their co-factors alters the formation of loops and TADs genome-wide, it seems to have only minor effects on gene expression [914], raising questions regarding the impact of chromatin structure upon genome function [15]. In this context, it was proposed that chromosome topology may refine the action and timing of distant enhancers on their target genes during development [1618], implying that the importance of such structures should be considered on a case-by-case basis, rather than drawing too global conclusions.

A useful experimental approach to study TADs and their boundaries in a locus-specific manner is to engineer alleles with deletions of specific elements. In some loci, deletions of boundaries or rearrangements of TADs were associated either to cancer [19] or to developmental defects, as seen for example with Xist [3], Wnt6/Ihh/Epha4/Pax3 [20], HoxD [21,22], Firre [23], Sox9/Kcnj2 [24] or Shh [25]. In contrast, while fewer examples exist where TAD boundaries were inserted into specific genomic locations, they showed different levels of impact upon the surrounding chromatin environment [23,26,27]. Therefore, the capacity of some DNA sequences to act as TAD borders and their effect on gene regulation might in part depend on the host genomic context. Alternatively, the ability of a given TAD boundary element to delimit a chromatin domain may be mostly encoded in its underlying sequence.

The TAD structure of the HoxD locus has been studied in some details. The HoxD gene cluster itself contains a strong TAD boundary separating two distinct regulatory landscapes referred to as C-DOM and T-DOM, each hosting series of enhancers. The T-DOM TAD is further divided into two sub-TADs at the level of a DNA segment called CS38-40, which contains a limb enhancer, a CpG island in close proximity to the transcription start site (TSS) of the Hog and Tog long non-coding RNAs (lncRNAs) and three occupied CTCF sites all oriented towards the gene cluster [21,22,28]. This region helps to properly implement the timing of limb enhancer action and constitutes a bona fide topological boundary, for its deletion abrogates the observed contact segregation, whereas its inversion reinforces it [18]. We wondered whether this boundary region would by itself carry the capacity to create a topological boundary when positioned into a different genomic context in vivo, and hence we generated transgenic mouse models with random ectopic integrations of this region. We report the ability of this region to be accessed by both CTCF and the cohesin complex, and show that this boundary was able to split the 1.2 Mb-large host TAD into two sub-structures. These topological changes were accompanied by a decrease in the expression of the Btg1 gene, the only protein-coding gene present inside the host TAD, further illustrating the functional impact of introducing CS38-40 at an ectopic site.

Results

Region CS38-40 is a sub-TAD boundary of the HoxD locus

Through series of deletions and inversions in vivo, we recently showed that region CS38-40, located within the large T-DOM TAD flanking the HoxD cluster, was capable to act as a topological border [18]. We further evaluated the properties of this region by generating Hi-C datasets using mouse limb cells at embryonic day 12.5 (E12.5) in a mutant line bearing a deletion of CS38-40 (del(CS38-40)) [18,29] along with wild-type control cells. We identified topological domains (TADs or sub-TADs) using the insulation-based hicFindTADs algorithm and confirmed the partitioning of the T-DOM TAD into two sub-domains at the level of CS38-40 in wild-type limbs. This boundary however appeared relatively weak and was only identified with the smallest window size that was applied (240 kb) (Fig 1A and 1C, light blue bars and track; S1 Table). Using the same algorithm and parameter values, we did not detect the splitting of the T-DOM in del(CS38-40) (Fig 1B, light red bar and S1 Table), demonstrating the merging of the two T-DOM sub-TADs into one single structure. Taken together, these results confirm that region CS38-40 is a bona fide sub-TAD border, validating previous observations [18,21,28].

Fig 1. Region CS38-40 is a sub-TAD boundary of the HoxD locus.

Fig 1

(A, B) Hi-C of the HoxD locus in wild-type (A) and del(CS38-40) (B) whole limbs at E12.5. Topological domains (TADs or sub-TADs) were identified using a window size (w) of 240 kb (light-coloured bars) or 480 kb (dark-coloured bars) and are represented below each Hi-C heatmap. (C) Insulation scores computed with two different window sizes (see above). (D) Wild-type ChIP-seq of CTCF in E12.5 whole limbs. CTCF orientations are indicated by red or blue arrowheads. (E) Magnification of region CS38-40 (mm10, chr2:75122684–75160161; highlighted in light green in previous panels) from panel D. The extension of the deletion in del(CS38-40) (mm10, chr2:75133816–75153815) is shown as a dashed line at the bottom.

Region CS38-40 contains three highly conserved non-coding sequences (CS38, CS39 and CS40) as well as a limb enhancer (comprised within CS39) and three CTCF sites oriented towards the HoxD cluster (Fig 1D and 1E). To evaluate the capacity of region CS38-40 to function as a sub-TAD boundary outside of its original genomic context, we performed random transgenesis by pronuclear injection of a 45 kb-large fosmid clone containing the entire region CS38-40 (Figs 1E and 2A). Because transgenes often integrate in multiple copies [30], we used a loxP/Cre system [31] to try and reduce the copy number to one and obtained a stable transgenic mouse line termed TgN(38–40).

Fig 2. Characterization of the TgN(38–40) integration.

Fig 2

(A) Schematic representation of the TgN(38–40) fosmid, vector in gray. Position of TLA viewpoints (lollipops) and qPCR primers (left to right: CS38, CS39 and CS40a) is indicated. (B) Transgenesis and characterization workflow. (C) Analysis of the TgN(38–40) integration by TLA. Top, TLA end-to-end coverage around the candidate integration site. Bottom, magnification of the above-mentioned area. Both end-to-end and CATG-filtered unmapped coverages are shown. Green arrows highlight sharp drops in the CATG-filtered unmapped signal. TLA restriction sites are shown below. (D) Top, TLA-derived genomic configuration. Asterisk, second partial CS38 element. Bottom, position of the two distinct pools of sgRNAs used for nCATS. (E) Analysis of the TgN(38–40) integration using MinION-nCATS. Dot plot representation of five selected MinION reads (ranging from 10 to 35 kb) along the TLA-derived configuration (horizontal axis), color-coded as in (D). The ~600 bp duplication of chromosome 10 sequence manifests as a subtle discontinuity in read 1 on the left as well as a small diagonal on the right.

Characterization of the TgN(38–40) integration

To locate the TgN(38–40) integration site, we carried out targeted locus amplification (TLA; Fig 2B) [32]. TLA is a 3C-derived technique based on fixation, enzymatic digestion, proximity ligation and inverse PCR from a specific locus of interest (viewpoint) that results in an over-representation of the sequences surrounding the viewpoint. Given the large ligation products of TLA (~2 kb), it is suitable for characterizing transgene-integration sites and chromosomal rearrangements with a base-pair resolution [3234]. We used TLA viewpoints corresponding to two regions of the transgene, one located in the vector backbone and the other matching the CS38 element. A primary TLA analysis assigned the integration site to a region located in chromosome 10 (Fig 2C, top two tracks and S1A Fig) and identified one of the integration breakpoints based on abrupt drops in the coverage of reads mapped in local mode (similar to [35], but with more filters; see the Materials and Methods section and examples in Fig 2C). This breakpoint connected the CS38 element to chromosome 10 (S3B and S3C Fig, TLA-identified right breakpoint). In addition, mapping the TLA data on the transgene sequence showed coverage along the whole construct (S1B Fig) and multiple reads supported a tail-to-head tandem junction, whereas none supported tail-to-tail nor head-to-head configurations (S1C Fig). Therefore, these results strongly suggested the integration of at least one full copy of the fosmid, fused tail-to-head with a truncated version of a second copy.

We then tried to determine how many copies of the TgN(38–40) construct were left after the Hprtcre cross and performed transgene quantification by qPCR on purified genomic DNA (gDNA) (Figs 2B and S2A). We compared samples that were hemizygous for the integration (TgN(38–40)/Wt) to wild-type (Wt) controls. To validate the qPCR approach, we used samples heterozygous for the deletion of the endogenous region CS38-40 in chromosome 2 (del(CS38-40)+/-) and a qPCR target region located outside CS38-40 (Hoxd8d9), which should not show amplification differences in any sample. In TgN(38–40) hemizygous animals, for which two copies of CS38-40 were attributed to the endogenous locus (reflecting the two non-deleted alleles), the ectopic (surplus) values of CS38, CS39 and CS40 were 1.46, 0.55 and 0.81, respectively (S2A Fig), thus showing that these elements were represented in variable copy numbers in the transgene.

We also used the control-free copy number and allelic content caller (Control-FREEC) (Figs 2B and S2B) [36], a maximum likelihood-based algorithm that evaluates copy number along genomic regions starting from NGS data. We applied Control-FREEC to gDNA libraries from specimens that were both hemizygous for the TgN(38–40) integration and homozygous for the endogenous CS38-40 deletion (TgN(38–40)/Wt; del(CS38-40)-/-; referred to as ‘test’) as well as from control samples to represent the endogenous region CS38-40 in chromosome 2. We obtained a copy number estimation close to four (using two different windowing functions) for the segment extending from the left end of the TgN(38–40) construct towards the CTCF site of CS38 (S2B Fig). Taken together, both the qPCR and Control-FREEC results indicated that the insert consisted of a single complete copy of region CS38-40, followed by a fragment extending towards a second but partial CS38 element. We thus constructed an in silico mutant genome composed of one entire copy of region CS38-40 and a partial copy including a truncated CS38 element in chromosome 10 (Fig 2D).

To validate this conclusion and to characterize the missing integration breakpoint, we implemented nanopore Cas9-targeted sequencing (MinION-nCATS; Fig 2B, 2D and 2E) [37]. We targeted two distinct combinations of single-guide RNAs (sgRNAs) around the insertion site and along the transgene (at approximately 10 kb intervals) in order to release overlapping DNA fragments ranging from 9.5 to 23 kb in size (Fig 2D; see nCATS tiling). The MinION sequencing reads were mapped onto the above-mentioned in silico mutant genomic configuration (Fig 2D).

The MinION coverage revealed an around 25 times enrichment of sequences originating from the targeted region compared to the rest of the genome (S4 Table). Inspection of five individual MinION reads enabled us to map the entire transgene integration (Fig 2E) and confirmed the presence of the additional partial copy of the construct that includes a second CS38 segment (with its CTCF site; see Fig 2E, read 5). Moreover, MinION unveiled a ca. 600 bp duplication of chromosomal sequence and primarily identified the missing (left) integration breakpoint in between the duplicated segments (Fig 2E, read 1). These results prompted us to design a TLA breakpoint analysis pipeline that considered more reads, which enabled the base-pair mapping of the left breakpoint (S3A Fig, red arrows; and S3B and S3C Fig, MinION-identified left breakpoint). Therefore, we established that the insertion of the TgN(38–40) construct in chromosome 10 resulted in a partial tail-to-head tandem, which consisted of one entire copy of the construct fused with an additional fragment including the CTCF site of the partial CS38 element. As a consequence, the insert spans 63.2 kb in total and comprises four CTCF sites, which are all sharing the same orientation. Both the TLA and MinION results indicated that the integration of the construct was not associated with any major genetic reshuffling of the host locus, except for the small duplication described above (S3C Fig).

Recruitment of architectural proteins on the relocated region CS38-40

We looked for the presence of both CTCF and the cohesin subunit RAD21 on the ectopic region CS38-40 by chromatin immunoprecipitation (ChIP) coupled with sequencing using whole limbs of TgN(38–40) embryos at E12.5 (Fig 3A). The transgene was brought on top of a deletion of both CS38-40 endogenous copies, such that all potential sequencing reads would derive from the transgenic locus. Mapping of the ChIP data onto the mm10 reference genome revealed the binding of CTCF on all three sites of CS38-40, as in the wild-type situation (Fig 3A, CTCF). The signal at the CTCF site of CS38 approximately corresponded to twice the signal at either of the other two sites, probably due to the additional copy (Fig 3A, see control regions in S4 Fig). Similar to what was observed for the control endogenous CS38-40 region, RAD21 was mostly enriched on the CS38 site (Fig 3A, RAD21). These results indicated that the recruitment of architectural proteins on region CS38-40 could occur independently from the global genomic context.

Fig 3. Recruitment of architectural proteins and topological changes upon integration of the TgN(38–40) construct.

Fig 3

(A) ChIP of CTCF and RAD21 in wild-type or TgN(38–40) E12.5 whole limbs. The window displayed corresponds to the native region CS38-40. Dashed lines are displayed for better comparison between the occupancy of various CTCF sites. Peak calling is represented as black boxes. Bottom, extension of both the TgN(38–40) construct and del(CS38-40) background. (B) Hi-C showing the host locus of chromosome 10 in wild-type whole limbs at E12.5. Below the Hi-C heatmap, wild-type CTCFs (red or blue arrowheads) and topological domains (horizontal bars). (C) Distribution of H3K27ac (green) over the host locus in the distal part of wild-type E12.5 forelimbs. (D) Top, 4C-seq using CS38 and CS40 as viewpoints in TgN(38–40) E12.5 limbs. Bottom, 4C-seq tracks of CTCF-left and CTCF-right viewpoints in both TgN(38–40) homozygous (red lines) and wild-type samples (blue lines). Percentages of 4C-seq contact changes beyond the integration site are shown. Black arrowheads indicate 4C-seq viewpoints. (E) ChIP of CTCF and RAD21 over the host landscape in TgN(38–40).

Alteration of local chromatin structure upon integration of the TgN(38–40) construct

We next investigated the conformational state of the region hosting the TgN(38–40) construct in chromosome 10 using our control Hi-C dataset and observed the presence of a 1.2 Mb-large, well defined TAD wherein the transgene had integrated (Fig 3B). This domain contains relatively few CTCF sites (~5 sites/Mb) as well as a single gene, Btg1 (Fig 3, bottom). Examination of published ChIP-seq datasets for the active histone mark H3K27 acetylation (H3K27ac) in E12.5 distal limb cells [22] revealed two strongly acetylated regions within the TAD, corresponding to either the promoter of the Btg1 gene, or a region at the telomeric (right) TAD border (Fig 3C).

We then assessed whether and how the four ectopic CTCF-binding sites would interfere with the host chromatin landscape, knowing that all four had the same orientation. We performed circular chromosome conformation capture-sequencing (4C-seq) using the CTCF sites present in the CS38 and CS40 elements as viewpoints in TgN(38–40) transgenic samples (Fig 3D, CS38 and CS40 tracks). Both CS38 and CS40 CTCF viewpoints established strong interactions with regions of their new genomic environment. Contacts were particularly frequent within the limits of the 1.2 Mb TAD hosting the transgene, suggesting that the surrounding landscape could constrain interactions originating from the ectopic DNA segment. Furthermore, maximum interaction frequencies were observed at CTCF sites displaying a convergent orientation relative to those of the transgene (Fig 3D, red arrows), in agreement with the loop extrusion model [7,8].

As additional viewpoints, we used two CTCF sites, also bound by RAD21 (Fig 3E), located at either extremity of the TAD (Fig 3D, CTCF-left and CTCF-right). In control limbs, both viewpoints established contacts mainly restricted to their own TAD (Fig 3D, blue tracks) and maximum contact frequencies were observed at convergent CTCF sites near the endogenous TAD boundaries (Fig 3D, blue arrows). To assess contacts in the TgN(38–40) samples without confounding effects due to the wild-type copy of this region, we carried out 4C-seq by using E12.5 limbs from embryos homozygous for TgN(38–40). Novel contacts were observed between these two CTCF sites and the sites located within the TgN(38–40) transgene (Fig 3D, CTCF-left and CTCF-right, red tracks), corroborating the results obtained when both CS38 and CS40 CTCF sites were used as viewpoints. Of note, the new loops appeared to occur at the expense of endogenous interactions, since contacts established by each of the two endogenous viewpoints were decreased beyond the integration site relative to the position of the viewpoint. This was particularly evident at the boundaries of the TAD. This decrease in interactions relative to the control ranged from 32% to 47% for CTCF-right and CTCF-left viewpoints, respectively.

Reconstitution of a sub-TAD boundary in the host landscape

These observations prompted us to evaluate whether the host TAD had been disrupted by the integration of the construct. We performed Hi-C in TgN(38–40) homozygous E12.5 limbs (Fig 4A–4C) and observed a split of the host TAD into two sub-domains, right at the level of the transgene insertion (Fig 4B, arrow). To better compare the wild-type and mutant Hi-C maps, we adapted the signal of the former to account for the potential effect of increasing the genomic distance. We thus calculated the value-of-alpha of the function relating contact frequencies to distance along the Btg1 TAD (S5A Fig, pink curve). Direct comparison of wild-type and mutant datasets showed a clear loss of interactions (-39%, p-value = 2e-29) between the two new sub-domains in a differential heatmap (Fig 4D, dashed box). The TAD partitioning was reminiscent of a sub-TAD boundary formation, for it was only detected by the hicFindTADs algorithm at a window size of 240 kb (Fig 4B and 4C, light red bars and track, S1 Table) and a substantial amount of interactions were scored across the new border (Fig 4B; asterisk), similar to what is observed at the endogenous CS38-40 region (Fig 1A, S1 Table and [18,21,22]). Therefore, the integration of the TgN(38–40) construct not only impaired interactions between discrete loci that were separated by the insertion, but was indeed capable of reshaping the topological organization of the host landscape.

Fig 4. Reconstitution of a sub-TAD boundary in the host landscape.

Fig 4

(A) Wild-type and (B) mutant TgN(38–40) Hi-C matrices of the host locus in whole limbs at E12.5. Corresponding CTCFs (red or blue arrowheads) and topological domains (horizontal bars) are shown. Below each panel, TAD-separation, color-coded according to the applied window size. The arrow indicates a new boundary at the level of the integration. (C) Insulation scores using two different window sizes. (D) Differential Hi-C heatmap (TgN(38–40)-Wt). Quantification of contacts changes between regions located across the TgN(38–40) integration site (dashed box), -39% (p-value = 2e-29). H3K27ac ChIP tracks. (E) Btg1 WISH in wild-type and TgN(38–40) homozygous E12.5 forelimbs. Scale bar: 500 μm. Fractional numbers indicate the proportion of embryos displaying equivalent patterns in the experiment. (F) RT-qPCR values of Btg1 and Tbp (internal control) in E12.5 distal forelimbs and liver. mRNAs levels were referenced to Actb (Wt = 31, TgN(38-40)/Wt = 27); p-values were obtained by Welch’s t-test. (G) Proposed mechanistic model of Btg1 expression changes. PE, putative Btg1 enhancer (green oval). Enhancer-promoter communication is represented with arrows.

Finally, we determined whether the integration of the construct and associated chromatin reorganization would cause any modification in the expression of the Btg1 gene (Figs 3 and 4), a gene involved in the regulation of cell proliferation [38]. Whole-mount in situ hybridization (WISH) of Btg1 in E9.5 embryos showed an ubiquitous expression in wild-type and mutant embryos, with no significant increase of limb expression associated to the limb enhancer contained in the transgene (S6A Fig). At E12.5, control embryos also revealed a widespread expression, with maximum transcript levels in the developing limbs, facial mesenchyme, whisker pads, lateral plate mesoderm and mammary buds (Figs 4E and S6B and S6C). In TgN(38–40) homozygous embryos, Btg1 appeared to be globally down-regulated, without any detectable morphological alteration (S6B Fig). The decrease in expression was particularly pronounced for the distal part of the limbs, the lateral plate mesoderm and the mammary buds (Figs 4E and S6B and S6C).

Further analyses by RT-qPCR confirmed that the insertion of the transgene had a negative effect on Btg1 expression in distal limbs, yet not in liver cells (Fig 4F) where the isolated sub-domain did not show any H3K27ac signal at the putative regulatory region (Fig 4D, right orange bar). These results indicated that the integration of the TgN(38–40) construct and/or the associated reorganization of the host chromatin landscape had an impact on Btg1 gene expression in a tissue specific-manner, most probably due to the isolation of a putative enhancer.

Discussion

We report the ability of the region CS38-40 from the HoxD locus to function as a topological boundary when introduced outside of its original genomic context. To interpret the results in a reliable manner, we characterized the transgene integration at a base-pair resolution, assessing both the number of copies and the absence of major chromosomal rearrangements. We concluded that the fosmid clone was present in one copy, plus a truncated piece containing another CTCF site, leading to the presence of four CTCFs with the same orientation. Indeed transgenes tend to integrate as concatemers, up to hundreds of copies, with the most common configuration being in tail-to-head [39], a situation that would have invalidated the observed effects. Also, even though the correct insertion of large pieces of DNA (BAC or fosmids) as transgenes has been usually considered as granted, the results of such insertions have rarely been verified at the appropriate level of resolution. Our detailed characterization of the insertion site, by using various strategies [3335,40], suggests that careful attention should be given to this aspect whenever using transgenic approaches to address questions related to chromatin organization.

Reproducing a sub-TAD boundary

TAD boundaries have been deleted in vivo at several loci and these alterations were associated with changes in gene expression (reviewed in [41]), whereas in other instances, topological borders were moved along with part of their regulatory domains through targeted inversions [18,24]. Such inversions and repositioning of TAD boundaries led to a new spatial organization and induced the down-regulation of genes whose access to their enhancers was hampered. These situations, however, make it difficult to disentangle how much of the topological and functional effects are due to the specific positioning of the TAD border from the impact of the large rearrangement of the regulatory landscape; in other words, to which level the specific initial chromatin environment is by itself required for the function of the boundary.

To date, only few studies have undertaken the opposite approach, whereby a boundary is moved to a completely new genomic location, and most of them were limited to mammalian cultured cells. Furthermore, the results of these studies seem to be influenced by several factors including the nature of the sequence, the host environment, as well as more technical aspects. For instance, Redolfi et al. (2019) found that the introduction of a 2.7 kb piggyBac cassette containing three CTCF-binding sites led to the formation of new DNA loops and stripes [26]. Others reported a clear TAD splitting after insertion of the HERV-H transposon in an 8.7 kb piggyBac. This splitting, however, required the expression of the transposon, rather than high CTCF binding levels, which are associated with most canonical TAD boundaries [42]. In another transposon-based study, a 2 kb fragment containing a CTCF-binding site and a transcription start site (TSS) was inserted multiple times across the genome and several cellular clones were analyzed. The authors reported various degrees of topological changes including the generation of new loops and domains, compartmental changes and domain fusion, whereas in some instances, no change was observed. Of note, some of the effects resulted from the combined action of transcription and CTCF binding and could be modulated by the host genomic context [27].

The only in embryo attempt consisted in the integration of the cDNA from the Firre lncRNA, which harbored one CTCF-binding site and an inducible TSS. However, this construct was not able to induce TAD splitting in any of multiple integration sites assessed [23]. In our case, we previously showed that region CS38-40 is responsible for the organization of the HoxD-associated T-DOM in two sub-TADs and that the orientation of the CTCF-binding sites was important in this context [18]. We now report that this capacity is intrinsic to its underlying sequence, at least for the chromosomal context analyzed in chromosome 10.

It is noteworthy that the increase in the linear genomic distance induced by the integration (63.2 kb) may have an effect on the 3D chromatin organization in our experimental setup. Nevertheless, the evidence provided here suggests that the capacity of a given sequence to restrict contacts to one side does not strictly depend on the linear distance. Indeed, deletions of several DNA fragments of various lengths (and CTCF-binding sites) at the HoxD TAD boundary did not lead to a complete fusion of the two surrounding domains, but only increased the permeability of the boundary [22]. Similarly, the removal of the whole Firre locus, spanning 82 kb and comprising twelve CTCF-binding sites, left the two surrounding TADs almost unaffected [23].

Disturbing a putative regulatory landscape

Our mouse model also allowed us to probe changes in gene expression in the vicinity of the integration site. The insertion of the TgN(38–40) construct took place in a large TAD that contains the single protein-coding gene Btg1, which has been implicated in maintaining the proliferation of neural stem cells [38]. We detected Btg1 transcripts in several tissues, including the facial region, the lateral plate mesoderm, the mammary buds and the limbs. A decrease of Btg1 expression was evident upon TgN(38–40) insertion, particularly in the limbs. In limbs, apart from the Btg1 gene itself, only a single other region appeared to be heavily decorated with H3K27ac, a histone mark associated with active genes and enhancers [43]. This H3K27ac-positive region was located at one of the TAD limits and became topologically isolated from Btg1 upon integration of TgN(38–40). Conversely, in the developing liver, this region did not show remarkable H3K27ac signal and, concomitantly, Btg1 mRNA levels were not affected by the integration of the transgene in this tissue. Although we cannot rule out other potential explanations, such as for example TgN(38–40) acting as a repressive regulatory sequence in this new context, we believe that the most plausible explanation for the downregulation of Btg1 in limbs is its isolation from the sole putative limb enhancer found within the host TAD (Fig 4G).

Materials and methods

A fully detailed version of all experimental procedures reported in this work can be found in [44] (https://zenodo.org/record/4292299).

Ethics statement

All experiments of this study were accepted by the Geneva Cantonal committee for animal experimentation and were performed in accordance with the Swiss Animal Welfare Act (LPA) under the license no. GE 81/14 (to D.D.).

Mutant mouse strains

The TgN(38–40) transgenic line was obtained by injecting the TgN(38–40) linearized fosmid (WI1-2299-I7; mm10, chr2: 75122702–75160145) into mouse fertilized oocytes at the pronuclear stage. 129S1/Sv-Hprttm1(CAG-cre)Mnn/J (abbreviated Hprtcre) mice, described in [31], were purchased from The Jackson Laboratory and were used for the removal of extra-copies of the transgene in case of tandem integration thanks to a loxP site located in the transgene vector. The HoxDdel(CS38-40) allele (abbreviated del(CS38-40)) was described previously [29]. All mutant mouse strains used in this study were maintained in a heterozygous state on a C57BL6xCBA background. Heterozygous individuals were crossed in order to generate embryos of all possible genotypes.

TLA

TLA was performed as in [32] with the following adaptations. Limb cells were dissociated using collagenase type XI (Sigma-Aldrich, C7657) and the cell suspension was strained. Transgene-positive (TgN(38–40)/-) samples were identified by PCR and two E12.5 brains were used as starting material. TLA inverse PCR was performed using the viewpoint-directed inverse PCR primers listed in S2 Table. TLA library preparation was achieved using the Nextera DNA Flex Library Prep (Illumina) protocol, independently for each viewpoint. Libraries were sequenced as 100 bp single-end reads with an Illumina HiSeq 4000. TLA data analysis was performed using the custom pipelines described hereafter. In brief, all alignments were produced using Bowtie 2 (version 2.3.5) [45] and were sorted with SAMtools (version 1.9) [46]. After filtering and adapter trimming with cutadapt [47], the reads were mapped on their entire length (end-to-end) onto the mm10 reference genome or a sequence built with 4 copies of the fosmid with different orientations (->-><- ->) and the coverage was computed using BEDTools (version 2.27.1) [48]. The coverage from reads mapped on mm10 with a mapping quality (MAPQ) above 30 was assigned to non-overlapping 1 Mb windows of mm10 in order to identify the candidate integration site as the genomic region with maximum TLA end-to-end coverage (not considering the HoxD locus, from which the transgene originated). In the first breakpoint analysis, reads not mapping on their entire length were mapped onto mm10 in local mode (i.e., allowing a segment of each read to not match). All reads containing a NlaIII site (CATG) were filtered out to exclude digestion-ligation events as relevant hybrid junctions, and the coverage was computed from the remaining reads (called CATG-filtered unmapped reads) (see output in Fig 2C, bottom tracks). In a second, more read-conservative breakpoint analysis, reads not mapping on their entire length onto mm10 were retrieved and were split at NlaIII sites. All split reads of more than 25 bp not mapping on their entire length to both mm10 and the transgene vector (called CATG-split unmapped reads) were mapped on mm10 and the transgene vector in local mode, followed by coverage computation (see output in S3A Fig). At last, and for both analyses, the resulting reads were inspected going from the mapped part (known) to the unmapped part (unknown) in order to determine which sequences were brought together through the computation of an average hybrid sequence from all reads displaying a particular connection (see examples in S3C Fig).

qPCR transgene quantification

Individual ear punches from adult mice were digested in proteinase K for 48 hours, followed by heat-inactivation of the enzyme at 96°C. gDNA was purified using phenol-chloroform extraction and ethanol precipitation. The qPCR was performed using PowerUp SYBR Green Master Mix (Thermo Fisher Scientific, A25742) in a QuantStudio 5 Real-Time PCR device (Thermo Fisher Scientific). The primers used are listed in S2 Table. For each sample, the results were normalized to the value of Aldh1a2 using the ΔCt method and outliers were discarded. The qPCR quantification shown in S2A Fig was produced using GraphPad Prism 8 and represents the values relative to the wild-type (2-ΔΔCt) multiplied by two in order to reflect absolute allele counts for each qPCR target region.

Control-FREEC transgene quantification

Copy number quantification was performed using Control-FREEC version 11.5 [36]. The signal from the ectopic CS38-40 (test dataset) was computed based on the TgN(38–40) total input gDNA data of the ChIPmentation experiment (see ChIPmentation below). Next, the signal from the endogenous region CS38-40 (control dataset) was created by pooling total input gDNA data of four samples that were all TgN(38–40)-negative and wild-type for region CS38-40 in chromosome 2, each processed independently. For both test and control datasets, the Control-FREEC signal, expressed as the number of reads scored for non-overlapping genomic windows of given sizes [49], was calculated along a 7 Mb region of chromosome 2 including the HoxD locus (chr2:71000000–78000000). The above analysis was carried out using two different window sizes: 1 and 2 kb (see S2B Fig). Then, the software calculated the test/control signal ratio, that is the number of reads from test divided by the number of reads from control, for each window, multiplied by two in order to obtain absolute allele counts. At last, the Control-FREEC software evaluated copy numbers along the 7 Mb chr2 region starting from the (test/control)·2 ratio by a maximum (log-)likelihood estimation [36].

MinION-nCATS

MinION-nCATS was performed as in [37], following the Cas-mediated PCR-free enrichment protocol (Oxford Nanopore Technologies) with a tiling approach. Single-guide RNAs (sgRNAs) were used instead of cr:tracrRNAs for target enrichment. Multiple pairs of sgRNAs were designed on the target region (Fig 2D, bottom) with Benchling (https://www.benchling.com/) and were converted into EnGen-compatible DNA oligos (listed in S3 Table) using NEBioCalculator (http://nebiocalculator.neb.com/#!/sgrna). sgRNAs were produced using the EnGen sgRNA Synthesis Kit, S. pyogenes (NEB, E3322) following the manufacturer’s instructions. Two distinct pools of sgRNAs and Alt-R S. pyogenes HiFi Cas9 nuclease V3 (IDT) were assembled into Cas9 ribonucleoprotein complexes. High molecular weight genomic DNA (HMW gDNA) was prepared as described hereafter, starting from a single E13.5 TgN(38–40)/TgN(38–40); del(CS38-40)-/- headless and tailless embryo. The sample was proteinase K digested in digestion buffer (50 mM Tris-HCl pH 8, 10 mM EDTA pH 8, 200 mM NaCl, 0.5% SDS) at 55°C while shaking for 48 hours. HMW gDNA was purified with two successive rounds of phenol-chloroform extraction, followed by ethanol precipitation. Size selection was carried out using 0.8x SPRI magnetic beads. nCATS was performed in two independent Cas9-mediated release reactions corresponding to the two different pools of sgRNAs and the products from both reactions were pooled together prior to sequencing on MIN106D flow cell. MinION output data in fast5 format were converted to fastq using the Guppy basecaller (version 3.1.5) (Oxford Nanopore Technologies) and the reads were mapped with minimap2 (version 2.15) onto mm10 and the TLA-derived configuration that assumed a 63.2 kb integration, comprising one entire copy of region CS38-40 followed by the partial CS38 segment, after position chr10:97019221 (mm10) (see Fig 2D, top). Reads mapping on the integration site (mm10, chr10:97018026–97020425) or transgene region (chr2:75122684–75160161 of mm10) sequence components of the TgN(38–40) mutant construction were converted from fastq to fasta in order to produce the dot plots displayed in Fig 2E. This was achieved using a Perl script as in [50], with the following modification: 20 bp of the MinION reads were tested against the reference for 5 bp-sliding windows and only 20-mers completely identical to unique 20-mers in the reference were kept. The output was then processed in R (www.r-project.org).

ChIPmentation

ChIPmentation was performed using the protocol of [51]. Tissues were crosslinked for 15 minutes and processed as in [52]. Four TgN(38–40)/Wt; del(CS38-40)-/- E12.5 whole limbs were used for the rest of the procedure. The description of experimental replicates is given in S8 Table. A fraction of the samples (see total input DNA below) was preserved to evaluate the efficiency of the chromatin immunoprecipitation by qPCR prior to sequencing and for the Control-FREEC analysis. Antibodies (CTCF, Active Motif 61311 or RAD21, Abcam ab992) were incubated with Dynabeads Protein A (Thermo Fisher Scientific, 10001D) for 3 hours on a rotating wheel at 4°C. Chromatin immunoprecipitation was performed overnight, followed by tagmentation for 2 minutes at 37°C. DNA libraries were sequenced as 50 bp single-end reads with an Illumina HiSeq 4000. ChIPmentation data analysis was performed as described in [52], mapping the reads on either the mm10 reference genome or TgN(38–40) custom genome, with the following adaptation: all reads were kept for the TgN(38–40) mapping and hence those aligning to the duplicated sequences were not discarded. These reads were randomly attributed to one or the other location. Due to different signal-to-noise ratios of wild-type and mutant data, the total enrichment of the CTCF ChIP signal was different on the normalized coverage tracks. To help in the visual comparison of the different CTCF ChIP tracks, we added a horizontal dashed line at values 3.5 and 1 for the wild-type and mutant ChIP tracks, which correspond to the height of their respective CS40 CTCF peaks at chromosome 2 (see Fig 3A). We kept the same ratios and placed the dashed lines at 8 and 2.3 in the other loci (see S4 Fig) when comparing the height of other CTCF peaks in the genome. Peak calling of CTCF and RAD21 was achieved using the MACS2 algorithm (Galaxy Version 2.1.1.20160309.3 with default parameters) [53,54] on each replicate and the union of the peaks obtained in each replicate was used in the figures. CTCF site orientation was determined using CTCFBSDB 2.0 (http://insulatordb.uthsc.edu/) [55] with MIT_LM7 motif position weight matrix.

4C-seq

4C-seq was performed as in [56]. For each genotype (i.e. wild-type or homozygous TgN(38–40)), samples corresponding to twelve E12.5 whole limbs were used as starting material. Inverse PCR was performed using 100 ng template DNA (for 14 reactions in total) and the viewpoint-directed primers listed in S2 Table. Libraries were multiplexed and sequenced to obtain 100 bp single-end reads with an Illumina HiSeq 2500. 4C-seq data analysis was performed as described on the HTSstation web interface (http://htsstation.epfl.ch) [57]. For both CS38 and CS40, the viewpoint was defined as the entire segment located between the two copies of CS38 (i.e., chr10:97036373–97082540, custom genome TgN(38–40)). The resulting scores were normalized to the mean score of fragments mapping within 10 Mb around the viewpoint and the signal was smoothened per 11 fragments. All 4C-seq mapped reads and fragment distribution are summarized in S6 and S7 Tables.

Hi-C

Hi-C was performed as in [5] and [58]. For each genotype (i.e. wild-type or TgN(38–40)/TgN(38–40); del(CS38-40)-/-), one sample corresponding to four E12.5 whole limbs was used as starting material. Hi-C libraries were multiplexed and sequenced so as to obtain 75/75 bp paired-end reads with an Illumina NextSeq (first run, 80 million reads per sample) or HiSeq 4000 (second run, idem). Hi-C data analysis was as in [58], with some modifications. HiCUP (version 0.7.3) [59] was applied providing either the mm10 reference genome, or the custom genome of TgN(38–40). For the TgN(38–40) mapping, the pipeline was adapted in order to prevent removal of reads aligning to the duplicated sequences of this line. All valid hybrid pairs were kept since no MAPQ filter was applied. Analysis of all hybrid pairs resulted in a Hi-C matrix binned at 40 kb, which was further processed using cooler (version 0.8.10) [60] for balancing normalization. All Hi-C sequencing outputs are summarized in S5 Table. TAD or boundary identification in Figs 1, 3 and 4 and S1 Table was done using the hicFindTADs tool from HiCExplorer suite (version 3.6) [6163] with a fixed window size of either 240 kb, 320 kb, 480 kb or 800 kb and applying Bonferroni p-value correction. To enable direct comparison of the Hi-C maps in Fig 4, the wild-type data were mapped on the mutant genome. However, as the effect of ca. 60 kb extra distance could thereby potentially be underestimated, we adapted the wild-type contact values according to the value of alpha (-0.42) obtained in S5 Fig, so as to faithfully reproduce the distance effect in the DNA stretch beyond the insertion site.

WISH

Whole-mount in situ hybridization (WISH) was performed as in [64]. The Btg1 RNA probe was generated by cloning cDNA of retrotranscribed RNA obtained from E9.5 whole embryos and using the following primer pair (forward: CTTTGGGTGGGCTCCTCT; reverse: TGGTGGTTTGTGGGAAAGA). To allow for direct comparison, all WISH experiments were done with E12.5 embryos of comparable sizes and were treated together in the same tubes. Pictures were taken with a Leica M205 FCA microscope equipped with a DFC 7000 T camera and were processed with Adobe Photoshop.

RT-qPCR

Distal forelimbs and livers were dissected from E12.5 wild-type (n = 31) and hemizygous embryos (TgN(38–40)/Wt) (n = 27) and kept in RNAlater (invitrogen) at -80°C. RNA was extracted with the RNAeasy Micro kit (QIAGEN) after shredding the tissue by pipetting it through a syringe with 27G needle. Reverse transcription was carried out using the GoScript Reverse Transcription System (Promega) and cDNA was amplified cyclically in a QuantStudio 5 Real-Time PCR device (Thermo Fisher Scientific). mRNA levels were referenced to Actb. Plotting and statistical analysis (Welch’s t-test) were performed with Prism software. The primers used for these experiments are listed in S2 Table. All raw Ct values are listed as S10 Table.

Sequencing data analysis and display

Chromatin immunoprecipitation (ChIP-seq and ChIPmentation) data were analyzed on our Galaxy platform [65]. Chromosome conformation capture (4C-seq and Hi-C), MinION and TLA data, as well as total input DNA data for Control-FREEC were analyzed through the Scientific IT and Application Support Center of the Ecole Polytechnique Fédérale de Lausanne (EPFL). Data were plotted using the pyGenomeTracks visualization tool (https://github.com/deeptools/pyGenomeTracks) [61,66]. Gene annotations shown in Figs 1, 3 and 4 were retrieved from GENCODE (GRCm38-mm10, VM23 protein-coding). The scripts used to generate all TLA, MinION, 4C-seq and Hi-C outputs as well as those used to produce NGS data figures were deposited in GitHub (https://github.com/lldelisle/scriptsForWilleminEtAl2021). All figures were processed with Adobe Illustrator.

TgN(38–40) in silico mutant genome reconstruction

As depicted in S3B Fig, the final in silico TgN(38–40) mutant genome reconstruction was built by inserting a 63812 bp sequence comprising (1) the entire TgN(38–40) fosmid (vector and chr2:75122684–75160161 of mm10), (2) an additional fragment of TgN(38–40) extending towards the CTCF of CS38 (see S3C Fig for details) and (3) the 602 bp duplicated region (mm10, chr10:97019222–97019824) inside chromosome 10 at position chr10:97019824 using the SeqinR package [67]. The sequence of the TgN(38–40) mutant chromosome 10 is available at (https://zenodo.org/record/4292337). The TgN(38–40) mutant genome was completed by adding wild-type chromosomes of mm10 (retrieved from UCSC), as well as the del(CS38-40) mutant chromosome 2 available at (https://zenodo.org/record/3826913) [18].

Quantifications of 4C-seq and Hi-C contact changes over the host TAD

The quantifications of 4C-seq contacts shown in Fig 3D were performed by summing non-smoothed 4C-seq scores, mapped onto the custom genome of TgN(38–40), over either the left (chr10:96120001–97019221, custom genome TgN(38–40)) or right segment (chr10:97083637–97400000, custom genome TgN(38–40)) of the host TAD. Both the integration and the 602 bp duplication of chromosome 10 were excluded from the analysis. The resulting values were normalized by the one obtained for the entire host TAD, for each genotype, and the fold change (fc) was computed as follows: fc = (TgN(38–40)-Wt)/Wt. This analysis was performed in R (https://www.r-project.org/). The quantification of Hi-C contacts in Fig 4D was achieved by retrieving the value of each bin in the new inter-sub-TAD space (chr10:96120000–97000000 and chr10:97080000–97400000, see dashed box) and the fc was computed as follows: fc = (mean(TgN(38–40))-mean(Wt))/mean(Wt). The p-value was obtained by a Mann-Whitney U-test. This analysis was performed in Python. All quantification scripts are available in the GitHub repository (https://github.com/lldelisle/scriptsForWilleminEtAl2021).

Supporting information

S1 Fig. Initial characterization of the TgN(38–40) mutant configuration by TLA (related to Fig 2).

(A) TLA signal mapped over all mm10 chromosomes (y-axis data range: 0–5000). Green arrowhead indicates region CS38-40, which composes the transgene, in chromosome 2. Brown arrowhead highlights the integration site in chromosome 10. Asterisk shows an artefactual peak of signal matching a satellite repeat. (B) TLA signal over the fosmid sequence. Below, fosmid scheme. (C) Assessment of all three different possible tandem configurations: tail-to-head, tail-to-tail and head-to-head. Coverage (top) and individual reads (bottom) supporting or dismissing each configuration. Candidate tandem connections are highlighted by a red dotted line. All data displayed in this figure were obtained using the vector viewpoint and correspond to the end-to-end coverage.

(EPS)

S2 Fig. Transgene quantifications using qPCR and Control-FREEC (related to Fig 2).

(A) qPCR of samples that were either wild-type (blue circles), heterozygous for the deletion of the endogenous region CS38-40 in chromosome 2 (del(CS38-40)+/-, green squares), or hemizygous for the integration (TgN(38–40)/Wt, red triangles). Transgene targets: CS38, CS39 and CS40a; control target: Hoxd8d9. Vertical axis reflects absolute allele counts. Means are indicated by solid black bars and values are shown above. (B) Control-FREEC transgene quantification using non-overlapping windows (w) of size 1 or 2 kb. Both (test/control)·2 signal ratio and copy numbers estimations (copy #) are shown along region CS38-40 (mm10 coordinates). The copy # signal represents absolute allele counts and the values are indicated in white within the corresponding tracks. Bottom, extension of the TgN(38–40) construct and del(CS38-40) background. In both panels, red and yellow lines indicate expected values for one and a half or two and a half fosmid copies, respectively.

(EPS)

S3 Fig. Base-pair map of the TgN(38–40) mutant genome (related to Fig 2).

(A) TLA reanalysis revealing left and right integration breakpoints (red and green arrows, respectively). The region displayed (mm10, chr10:97019018–97020046) is centered around the validated integration site (mm10, chr10:97019222–97019824). Both end-to-end and CATG-split unmapped coverages are shown. TLA restriction sites are shown at the bottom of the panel. (B) Schematic reconstruction of the TgN(38–40) integration. (C) Connections between chromosome 10 and the construct (left breakpoint, red; right breakpoint, green). Sequences are color-coded and/or underlined according to their origin. All identified connections were found in such a sequence configuration that the Watson strands of the transgene (tg) and chromosome 10 were fused. The asterisk indicates the limits of the 602 bp duplication.

(EPS)

S4 Fig

ChIP of CTCF in several control loci at (A) chromosome 1, (B) chromosome 8 and (C) chromosome 19 (related to Fig 3). Dashed horizontal lines are displayed for indirect comparison with CTCF binding at region CS38-40 (see Materials and Methods).

(EPS)

S5 Fig. Frequency of interactions and genomic distances (related to Fig 4).

(A) Logarithmic relationship between interaction probability and increasing genomic distances computed from the Hi-C data of wild-type limbs. These calculations were applied genome-wide, to an aggregate of all TADs in the genome and to individual TADs including the Btg1 TAD at chromosome 10 and six other TADs in the same chromosome. Values of alpha and R-value are shown for each condition. (B) Hi-C map depicting TADs 1–8 analyzed in (A).

(EPS)

S6 Fig. Global Btg1 expression changes upon reorganization of the host chromatin landscape (related to Figs 3 and 4).

(A) Btg1 WISH in wild-type and TgN(38–40) mutant embryos at E9.5. Heads were partially severed and used for genotyping. Arrowheads point to the area where the presumptive limb bud is located. Scale bar: 500 μm. (B) Btg1 WISH in wild-type and TgN(38–40) homozygous embryos at E12.5. LPM: Lateral plate mesoderm. FM/WP: Facial mesenchyme and whisker pads. Scale bar: 1 mm. (C) Magnified pictures of mammary buds for the same embryos as in panel B. The position of the forelimbs, which were removed for easier mammary bud visualization, is highlighted by a dotted line. Scale bar: 300 μm. The proportion of embryos displaying equivalent patterns in each experiment is shown. Empty arrowheads indicate changes in expression compared to bold arrowheads.

(TIF)

S1 Table. Identification of topological boundaries using various window sizes.

Source data (for different genotypes and mapped genomes) and TAD calling window sizes (w) are indicated. At the HoxD locus, Atf2 is the left boundary of the C-DOM and Hnrnpa3 is the right boundary of the T-DOM. Left_Bd and Right_Bd are respectively the left and right boundaries of the TAD hosting the TgN(38–40) construct in chromosome 10 (see Figs 3B and 4A).

(DOCX)

S2 Table. List of TLA, qPCR, 4C-seq and RT-qPCR primers used in this study.

For the 4C-seq primers, Illumina Solexa sequencing adapters are indicated in red (long adapter) or blue (short adapter). For both CS38 and CS40 viewpoints, a 4 bp barcode (underlined) was present between the long sequencing adapter and the rest of the primer. F: forward. R: reverse. iF: inverse forward. iR: inverse reverse.

(DOCX)

S3 Table. EnGen-compatible DNA oligos used as templates for sgRNA production.

The name of the oligos indicates their approximate position on the TgN(38–40) transgene or surrounding regions: upstream of the transgene in chr 10 (up); one quarter (1/4), halfway (1/2) or three quarters (3/4) into the transgene; 3’ part of transgene vector (pEpi3) and downstream of the transgene in chr10 (down). Two pairs of primers (1 or 2) were design to target the same region. Underlined, sequence matching target DNA. Red, sequence of the T7 promoter for sgRNA production. Cyan, RNA scaffold for the Cas9 enzyme. A G was added (highlighted in black) when not present in the original target sequence, to ensure efficient sgRNA transcription.

(DOCX)

S4 Table. Summary of the MinION sequencing output.

Target reads are reads mapping to the construct or the integration site. Construct coordinates taken into consideration: chr2:75123000–75160000 (mm10). Considered integration site: chr10:97018700–97019300 (mm10). *Ratio of bases of the mutant construction (64,420 bp; see Fig 2D) relative to the haploid mouse genome (around 2.6 Gb): 2.457384e-05.

(DOCX)

S5 Table. Summary of the Hi-C sequencing output.

Two samples were sequenced: TgN3840 (mutant) and Wt (control). Both were subsequently mapped either on mm10 wild-type mouse genome or the custom TgN(38–40) genome. Total reads correspond to all raw reads obtained from the sequencing platform. Cis-far reads correspond to intra-chromosomal interactions located further than 10 kb. All sequencing outputs are shown as base pairs (bp).

(DOCX)

S6 Table. Summary of mapped reads from 4C-seq experiments.

(DOCX)

S7 Table. Summary of 4C-seq fragment distribution.

(DOCX)

S8 Table. Biological replicates of the ChIP-seq and ChIPmentation (ChIPm) experiments.

Wild-type ChIP-seq data of CTCF, RAD21, and H3K27ac were retrieved from a previous publication of our group (see Data availability). WL: whole limbs. DFL: distal forelimbs.

(DOCX)

S9 Table. Genotypes of 4C-seq and Hi-C samples.

Genotypes of 4C-seq samples are colored in the same way than the corresponding tracks of Fig 3. WL: whole limbs (including both forelimbs and hindlimbs).

(DOCX)

S10 Table. Spreadsheets of Ct values coming from the RT-qPCR experiments done in limbs and livers from wild-type and hemizygous embryos (TgN(38–40)/Wt).

(XLSX)

Acknowledgments

We would like to thank Thi Hanh Nguyen Huynh, Sandra Gitto and Bénédicte Mascrez for help with mice breeding and genotyping; Mylène Docquier, Brice Petit, Didier Chollet and Christelle Barraclough from the Geneva Genomics Platform, as well as Bastien Mangeat, Elisa Cora and Lionel Sylvain Ponsonnet from the EPFL Gene Expression Core Facility. We are grateful to all members of the Duboule laboratories for comments and discussions.

Data Availability

All datasets produced in this study were deposited in the Gene Expression Omnibus (GEO) under the accession number GSE166584.

Funding Statement

DD received support under Grant No. 310030B_138662 from the Swiss National Research Foundation (http://www.snf.ch), Grant SystemHox No. 232790 from the European Research Council (https://erc.europa.eu), Grant RegulHox No. 588029 from the European Research Council (https://erc.europa.eu). L. L-D. was supported by the ERC grant RegulHox (No 588029, to D.D.) C. C. B. by a fellowship of the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (No F32HD093555, to C.C.B.) https://www.nichd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Misteli T. The Self-Organizing Genome: Principles of Genome Architecture and Function. Cell. 2020;0. doi: 10.1016/j.cell.2020.09.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485: 376–380. doi: 10.1038/nature11082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N, et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature. 2012;485: 381–385. doi: 10.1038/nature11049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gong Y, Lazaris C, Sakellaropoulos T, Lozano A, Kambadur P, Ntziachristos P, et al. Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries. Nature Communications. 2018;9: 542. doi: 10.1038/s41467-018-03017-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A three-dimensional map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159: 1665–1680. doi: 10.1016/j.cell.2014.11.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sun JH, Zhou L, Emerson DJ, Phyo SA, Titus KR, Gong W, et al. Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries. Cell. 2018;175: 224–238.e15. doi: 10.1016/j.cell.2018.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fudenberg G, Imakaev M, Lu C, Goloborodko A, Abdennur N, Mirny LA. Formation of Chromosomal Domains by Loop Extrusion. Cell Rep. 2016;15: 2038–2049. doi: 10.1016/j.celrep.2016.04.085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sanborn AL, Rao SSP, Huang S-C, Durand NC, Huntley MH, Jewett AI, et al. Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes. Proc Natl Acad Sci USA. 2015;112: E6456–6465. doi: 10.1073/pnas.1518552112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Haarhuis JHI, van der Weide RH, Blomen VA, Yáñez-Cuna JO, Amendola M, van Ruiten MS, et al. The Cohesin Release Factor WAPL Restricts Chromatin Loop Extension. Cell. 2017;169: 693–707.e14. doi: 10.1016/j.cell.2017.04.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nora EP, Goloborodko A, Valton A-L, Gibcus JH, Uebersohn A, Abdennur N, et al. Targeted Degradation of CTCF Decouples Local Insulation of Chromosome Domains from Genomic Compartmentalization. Cell. 2017;169: 930–944.e22. doi: 10.1016/j.cell.2017.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rao SSP, Huang S-C, Glenn St Hilaire B, Engreitz JM, Perez EM, Kieffer-Kwon K-R, et al. Cohesin Loss Eliminates All Loop Domains. Cell. 2017;171: 305–320.e24. doi: 10.1016/j.cell.2017.09.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Schwarzer W, Abdennur N, Goloborodko A, Pekowska A, Fudenberg G, Loe-Mie Y, et al. Two independent modes of chromatin organization revealed by cohesin removal. Nature. 2017;551: 51–56. doi: 10.1038/nature24281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Soshnikova N, Montavon T, Leleu M, Galjart N, Duboule D. Functional Analysis of CTCF During Mammalian Limb Development. Developmental Cell. 2010;19: 819–830. doi: 10.1016/j.devcel.2010.11.009 [DOI] [PubMed] [Google Scholar]
  • 14.Wutz G, Várnai C, Nagasaka K, Cisneros DA, Stocsits RR, Tang W, et al. Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteins. The EMBO Journal. 2017;36: e201798004. doi: 10.15252/embj.201798004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ghavi-Helm Y. Functional Consequences of Chromosomal Rearrangements on Gene Expression: Not So Deleterious After All? Journal of Molecular Biology. 2020;432: 665–675. doi: 10.1016/j.jmb.2019.09.010 [DOI] [PubMed] [Google Scholar]
  • 16.Bolt CC, Duboule D. The regulatory landscapes of developmental genes. Development. 2020;147. doi: 10.1242/dev.171736 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fukaya T, Lim B, Levine M. Enhancer Control of Transcriptional Bursting. Cell. 2016;166: 358–368. doi: 10.1016/j.cell.2016.05.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rodríguez-Carballo E, Lopez-Delisle L, Willemin A, Beccari L, Gitto S, Mascrez B, et al. Chromatin topology and the timing of enhancer function at the HoxD locus. PNAS. 2020. [cited 24 Nov 2020]. doi: 10.1073/pnas.2015083117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hnisz D, Weintraub AS, Day DS, Valton A-L, Bak RO, Li CH, et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science. 2016;351: 1454–1458. doi: 10.1126/science.aad9024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lupiáñez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, et al. Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions. Cell. 2015;161: 1012–1025. doi: 10.1016/j.cell.2015.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Andrey G, Montavon T, Mascrez B, Gonzalez F, Noordermeer D, Leleu M, et al. A switch between topological domains underlies HoxD genes collinearity in mouse limbs. Science. 2013;340: 1234167. doi: 10.1126/science.1234167 [DOI] [PubMed] [Google Scholar]
  • 22.Rodríguez-Carballo E, Lopez-Delisle L, Zhan Y, Fabre PJ, Beccari L, El-Idrissi I, et al. The HoxD cluster is a dynamic and resilient TAD boundary controlling the segregation of antagonistic regulatory landscapes. Genes Dev. 2017;31: 2264–2281. doi: 10.1101/gad.307769.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Barutcu AR, Maass PG, Lewandowski JP, Weiner CL, Rinn JL. A TAD boundary is preserved upon deletion of the CTCF-rich Firre locus. Nat Commun. 2018;9: 1444. doi: 10.1038/s41467-018-03614-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Despang A, Schöpflin R, Franke M, Ali S, Jerković I, Paliou C, et al. Functional dissection of the Sox9 –Kcnj2 locus identifies nonessential and instructive roles of TAD architecture. Nature Genetics. 2019;51: 1263–1271. doi: 10.1038/s41588-019-0466-z [DOI] [PubMed] [Google Scholar]
  • 25.Williamson I, Kane L, Devenney PS, Flyamer IM, Anderson E, Kilanowski F, et al. Developmentally regulated Shh expression is robust to TAD perturbations. Development. 2019;146. doi: 10.1242/dev.179523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Redolfi J, Zhan Y, Valdes-Quezada C, Kryzhanovska M, Guerreiro I, Iesmantavicius V, et al. DamC reveals principles of chromatin folding in vivo without crosslinking and ligation. Nature Structural & Molecular Biology. 2019;26: 471–480. doi: 10.1038/s41594-019-0231-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang D, Huang P, Sharma M, Keller CA, Giardine B, Zhang H, et al. Alteration of genome folding via contact domain boundary insertion. Nature Genetics. 2020;52: 1076–1087. doi: 10.1038/s41588-020-0680-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Delpretti S, Montavon T, Leleu M, Joye E, Tzika A, Milinkovitch M, et al. Multiple Enhancers Regulate Hoxd Genes and the Hotdog LncRNA during Cecum Budding. Cell Reports. 2013;5: 137–150. doi: 10.1016/j.celrep.2013.09.002 [DOI] [PubMed] [Google Scholar]
  • 29.Schep R, Necsulea A, Rodríguez-Carballo E, Guerreiro I, Andrey G, Huynh THN, et al. Control of Hoxd gene transcription in the mammary bud by hijacking a preexisting regulatory landscape. PNAS. 2016;113: E7720–E7729. doi: 10.1073/pnas.1617141113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Palmiter RD, Brinster RL. Germ-line transformation of mice. Annu Rev Genet. 1986;20: 465–499. doi: 10.1146/annurev.ge.20.120186.002341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tang S-HE, Silva FJ, Tsark WMK, Mann JR. A cre/loxP-deleter transgenic line in mouse strain 129S1/ SvImJ. genesis. 2002;32: 199–202. doi: 10.1002/gene.10030 [DOI] [PubMed] [Google Scholar]
  • 32.de Vree PJP, de Wit E, Yilmaz M, van de Heijning M, Klous P, Verstegen MJAM, et al. Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nature Biotechnology. 2014;32: 1019–1025. doi: 10.1038/nbt.2959 [DOI] [PubMed] [Google Scholar]
  • 33.Goodwin LO, Splinter E, Davis TL, Urban R, He H, Braun RE, et al. Large-scale discovery of mouse transgenic integration sites reveals frequent structural variation and insertional mutagenesis. Genome Res. 2019; gr.233866.117. doi: 10.1101/gr.233866.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Laboulaye MA, Duan X, Qiao M, Whitney IE, Sanes JR. Mapping Transgene Insertion Sites Reveals Complex Interactions Between Mouse Transgenes and Neighboring Endogenous Genes. Front Mol Neurosci. 2018;11. doi: 10.3389/fnmol.2018.00011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cain-Hom C, Splinter E, van Min M, Simonis M, van de Heijning M, Martinez M, et al. Efficient mapping of transgene integration sites and local structural changes in Cre transgenic mice using targeted locus amplification. Nucleic Acids Res. 2017;45: e62–e62. doi: 10.1093/nar/gkw1329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Boeva V, Popova T, Bleakley K, Chiche P, Cappo J, Schleiermacher G, et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics. 2012;28: 423–425. doi: 10.1093/bioinformatics/btr670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gilpatrick T, Lee I, Graham JE, Raimondeau E, Bowen R, Heron A, et al. Targeted nanopore sequencing with Cas9-guided adapter ligation. Nature Biotechnology. 2020;38: 433–438. doi: 10.1038/s41587-020-0407-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Farioli-Vecchioli S, Micheli L, Saraulli D, Ceccarelli M, Cannas S, Scardigli R, et al. Btg1 is Required to Maintain the Pool of Stem and Progenitor Cells of the Dentate Gyrus and Subventricular Zone. Front Neurosci. 2012;6. doi: 10.3389/fnins.2012.00006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Smirnov A, Fishman V, Yunusova A, Korablev A, Serova I, Skryabin BV, et al. DNA barcoding reveals that injected transgenes are predominantly processed by homologous recombination in mouse zygote. Nucleic Acids Research. 2020;48: 719–735. doi: 10.1093/nar/gkz1085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hottentot QP, Van Min M, Splinter E, White SJ. Targeted locus amplification and next-generation sequencing. Methods in Molecular Biology. Humana Press Inc.; 2017. pp. 185–196. doi: 10.1007/978-1-4939-6442-0_13 [DOI] [PubMed] [Google Scholar]
  • 41.Ibrahim DM, Mundlos S. Three-dimensional chromatin in disease: What holds us together and what drives us apart? Current Opinion in Cell Biology. 2020;64: 1–9. doi: 10.1016/j.ceb.2020.01.003 [DOI] [PubMed] [Google Scholar]
  • 42.Zhang Y, Li T, Preissl S, Amaral ML, Grinstein JD, Farah EN, et al. Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells. Nature Genetics. 2019;51: 1380–1388. doi: 10.1038/s41588-019-0479-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA. 2010;107: 21931–21936. doi: 10.1073/pnas.1016071107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Willemin A. Study of the HoxD locus topological boundaries inside and outside from their genomic context. University of Geneva. 2020. Available: https://archive-ouverte.unige.ch/unige:140175 [Google Scholar]
  • 45.Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature Methods. 2012;9: 357–359. doi: 10.1038/nmeth.1923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25: 2078–2079. doi: 10.1093/bioinformatics/btp352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17: 10–12. doi: 10.14806/ej.17.1.200 [DOI] [Google Scholar]
  • 48.Quinlan AR. BEDTools: The Swiss-Army Tool for Genome Feature Analysis. Current Protocols in Bioinformatics. 2014;47: 11.12.1–11.12.34. doi: 10.1002/0471250953.bi1112s47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Boeva V, Zinovyev A, Bleakley K, Vert J-P, Janoueix-Lerosey I, Delattre O, et al. Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. Bioinformatics. 2011;27: 268–269. doi: 10.1093/bioinformatics/btq635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Nicholls PK, Bellott DW, Cho T-J, Pyntikova T, Page DC. Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. G3: Genes, Genomes, Genetics. 2019;9: 1481–1486. doi: 10.1534/g3.119.300582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Schmidl C, Rendeiro AF, Sheffield NC, Bock C. ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors. Nature Methods. 2015;12: 963–965. doi: 10.1038/nmeth.3542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Rodríguez-Carballo E, Lopez-Delisle L, Yakushiji-Kaminatsui N, Ullate-Agote A, Duboule D. Impact of genome architecture on the functional activation and repression of Hox regulatory landscapes. BMC Biology. 2019;17: 55. doi: 10.1186/s12915-019-0677-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Feng J, Liu T, Qin B, Zhang Y, Liu XS. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7. doi: 10.1038/nprot.2012.101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based Analysis of ChIP-Seq (MACS). Genome Biology. 2008;9: R137. doi: 10.1186/gb-2008-9-9-r137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Ziebarth JD, Bhattacharya A, Cui Y. CTCFBSDB 2.0: a database for CTCF-binding sites and genome organization. Nucleic Acids Res. 2013;41: D188–D194. doi: 10.1093/nar/gks1165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Noordermeer D, Leleu M, Splinter E, Rougemont J, Laat WD, Duboule D. The Dynamic Architecture of Hox Gene Clusters. Science. 2011;334: 222–225. doi: 10.1126/science.1207194 [DOI] [PubMed] [Google Scholar]
  • 57.David FPA, Delafontaine J, Carat S, Ross FJ, Lefebvre G, Jarosz Y, et al. HTSstation: A Web Application and Open-Access Libraries for High-Throughput Sequencing Data Analysis. PLOS ONE. 2014;9: e85879. doi: 10.1371/journal.pone.0085879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Yakushiji-Kaminatsui N, Lopez-Delisle L, Bolt CC, Andrey G, Beccari L, Duboule D. Similarities and differences in the regulation of HoxD genes during chick and mouse limb development. PLoS Biol. 2018;16. doi: 10.1371/journal.pbio.3000004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Wingett SW, Ewels P, Furlan-Magaril M, Nagano T, Schoenfelder S, Fraser P, et al. HiCUP: pipeline for mapping and processing Hi-C data. F1000Res. 2015;4: 1310. doi: 10.12688/f1000research.7334.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Abdennur N, Mirny LA. Cooler: scalable storage for Hi-C data and other genomically labeled arrays. Bioinformatics. 2020;36: 311–316. doi: 10.1093/bioinformatics/btz540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Ramírez F, Bhardwaj V, Arrigoni L, Lam KC, Grüning BA, Villaveces J, et al. High-resolution TADs reveal DNA sequences underlying genome organization in flies. Nature Communications. 2018;9: 1–15. doi: 10.1038/s41467-017-02088-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wolff J, Bhardwaj V, Nothjunge S, Richard G, Renschler G, Gilsbach R, et al. Galaxy HiCExplorer: a web server for reproducible Hi-C data analysis, quality control and visualization. Nucleic Acids Res. 2018;46: W11–W16. doi: 10.1093/nar/gky504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Wolff J, Rabbani L, Gilsbach R, Richard G, Manke T, Backofen R, et al. Galaxy HiCExplorer 3: a web server for reproducible Hi-C, capture Hi-C and single-cell Hi-C data analysis, quality control and visualization. Nucleic Acids Res. 2020;48: W177–W184. doi: 10.1093/nar/gkaa220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Woltering JM, Vonk FJ, Müller H, Bardine N, Tuduce IL, de Bakker MAG, et al. Axial patterning in snakes and caecilians: Evidence for an alternative interpretation of the Hox code. Developmental Biology. 2009;332: 82–89. doi: 10.1016/j.ydbio.2009.04.031 [DOI] [PubMed] [Google Scholar]
  • 65.Afgan E, Baker D, Batut B, van den Beek M, Bouvier D, Čech M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46: W537–W544. doi: 10.1093/nar/gky379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Lopez-Delisle L, Rabbani L, Wolff J, Bhardwaj V, Backofen R, Grüning B, et al. pyGenomeTracks: reproducible plots for multivariate genomic data sets. Bioinformatics. 2020. [cited 16 Dec 2020]. doi: 10.1093/bioinformatics/btaa692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Charif D, Lobry JR. SeqinR 1.0–2: A Contributed Package to the R Project for Statistical Computing Devoted to Biological Sequences Retrieval and Analysis. Structural Approaches to Sequence Evolution: Molecules, Networks, Populations, Biological and Medical Physics, Biomedical Engineering. 2007; 207. doi: 10.1007/978-3-540-35306-5_10 [DOI] [Google Scholar]

Decision Letter 0

Gregory S Barsh, Stefan Mundlos

17 Mar 2021

Dear Dr Duboule,

Thank you very much for submitting your Research Article entitled 'CONTEXT-INDEPENDENT FUNCTION OF A CHROMATIN BOUNDARY IN VIVO' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Stefan Mundlos

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This is an interesting study reporting the first accurate characterization of the in vivo structural and functional effects of an ectopic insertion of genomic sequence containing a TAD boundary. The experiments meet high technical standards and in addition to providing interesting insight into the role of chromosome topology, also highlight the fact that every ectopic insertion deserves very careful examination before its structural and functional impact can be assessed.

The main limitation of the manuscript is that only one ectopic location and one version of the ectopic sequence are analyzed. This makes it hard to infer how generally the results can be extrapolated, and also to formally conclude on the mechanistic role of CTCF sites and loop extrusion in establishing the interactions observed at the ectopic location. I do not think however that this should be held up against the manuscript, given the complexity and timescales of in vivo experiments.

I only have a very small number of comments and suggestions (#1 is crucial though):

1) I would like to point the authors to the fact that the differential analysis of Hi-C data (Fig. 4) is not formally correct. Simply inserting a blank space in the WT map does not account for the correct decay of contact probabilities that would be generated by ~60kb of extra genomic sequence, even in the complete absence of CTCF sites or any other sequences that can create specific interactions. This is due to the power-law behavior of contact probabilities and 60 kb can make a big difference!

In order to conclude that sequence identity (rather than length) is responsible for the appearance of an extra sub-TAD boundary, the transgenic sample should be compared to a better (although not perfect) control where the WT counts across the insertion are rescaled by the average power-law decay inside the original TAD, which can be extracted from the WT Hi-C map. The formally correct control, which however seems out of experimental reach in the context of this study, would be a line carrying the homozygous insertion of the same ectopic sequence without CTCF sites.

2) In Fig. 4C it is unclear what the scalebar represents.

3) It would be very interesting to explore to which extent the amount of Btg1 downregulation depends on the amount of physical insulation provided by the ectopic boundary. For example does it depend on the number of CTCF sites in the boundary, as recently reported (Huang et al., https://www.biorxiv.org/content/10.1101/2020.07.07.192526v1)? The homozygous TgN(38-40) line provides an ideal background for generating CRISPR deletions affecting the number of CTCF sites in the transgenic boundary.

4) It would be nice to see higher magnification Hi-C maps – it looks like the number of reads in the experiments is not reported (should be included in a revised version) but from a qualitative assessment of the maps provided, this could be feasible.

Reviewer #2: In this work the authors use mouse transgenesis to randomly insert a previously characterized TAD subdomain boundary from the HoxD locus randomly into the mouse genome. First, the authors in detail characterize the transgene insertion in the Btg1 locus using a elaborate combination of state of the art approaches and find that the boundary to be inserted in a partial tandem copy within the Btg1 TAD. Following this, the authors characterize the effects of the inserted boundary on 3D chromatin structure and find that also at the new location the boundary element consisting of 4 CTCF sites (3+1 duplicated) serves as a sub-domain boundary (and not a "full/strong" boundary) that allows some contacts beyond the insertion point. Using in situ hybridizations of E12.5 embryos the authors show that the insertions leads to an overall reduced expression level of Btg1 without major changes in expression pattern.

The in-depth analysis of the transgene insertion using multiple analogous methods can serve as a case example of how to comprehensively characterize new transgenes, especially for studies that "assume" that the knock-in happened as predicted in theory.

The characterization of the 3D chromatin effects that originate from the sub-domain boundary are interesting, although limited in scope, given that only one alternative boundary position is analyzed. Stik et al in HAP1 cells and Huang et al (https://www.biorxiv.org/content/10.1101/2020.07.07.192526v1) in mouse embryonic stem cells have taken an alternative approach and characterized several integrations in cell culture systems. However, the in vivo approach taken here enables a more comprehensive functional readout at an organismal level similar to our own boundary repositioning at the Sox9 locus.

Therefore, the characterization of the gene regulatory effects of the boundary insertion should be more comprehensive in order to fully realize the potential of in vivo approach that the authors undertook. I would suggest including additional data that should be available or easily attainable to the authors (if the mouse line is still available) prior to publication.

Major comments:

Regulatory effects 1:

The authors should expand the regulatory consequences of the CS38-40 insertion into the Btg1 domain on Btg1 expression. As the authors have previously shown (Andrey et al 2013, Rodriguez-Carballo et al 2020), CS39 comprises a potent limb bud enhancer that is particularly active at stages prior to E12.5 and the TSS of two lncRNAs. If the mouse lines are available, it would be very informative to determine whether this leads to increased Btg1 levels at these early stages, assessed through WISH, but preferably also through more quantitative methods. Also, do lncRNA transcripts arise from the knock-in construct?

Regulatory effects 2:

Using publicly available data, such as chromatin ChIP-seq from the mouse ENCODE dataset, the authors could identify embryonic or adult tissues where the majority of regulatory elements is not cut off from Btg1 by the boundary insertion (kidney? heart? brain?). In these tissues (that could be obtained from the same crosses as used above) the loss of Btg1 expression should be less that in E12.5 limb buds. This data would strengthen the observation that the inserted boundary cuts off Btg1 from its major limb enhancers and the right Btg1 TAD boundary.

Reviewer #3: Defining the characteristics that are required for the formation of topological boundaries has received significant attention, including genetic experiments, biochemical analyses, computational, and modeling studies. Analysis of TAD boundaries has largely focused on use of deletions of chromosomal regions, or acute deletion of specific motifs such as CTCF binding sites, but relatively few studies have examined if the underlying DNA sequence can encode a boundary in different chromatin contexts.

In this manuscript the authors ask whether repositioning of a strong, CTCF-bound element from the HoxD cluster retains its potential to insulate chromatin when placed in an ectopic genomic context. The strength of this manuscript is in the novelty of performing this experiment using an in vivo context. However, as the boundary is moved to only one ectopic context, it cannot be determined if the results discussed herein can be extrapolated to additional regulatory sequences, for example boundaries with weaker insulation scores, or to different chromatin contexts.

Overall, the authors included excellent characterization of the integration site and the type of insertion event and have shown that the Tg mice of the large fragment acts similarly at the insertion site to its role in the endogenous environment. I think this work is sufficiently novel and would be of interest to the community, provided that the following comments are addressed:

Major points:

1. Title

I feel that the claim in the title is a bit misleading – there is only one integration site, so it is a bit of a stretch to conclude that the context doesn’t matter. In addition, the integrated sequence contains 4 CTCF reverse sites – would it still act as a boundary if it was in a context with no adjacent CTCF sites (for example in a compartmental domain or in another species where loop-extrusion loops are not so prominent such as drosophila)? To be clear, I don’t think that these experiments are required, I would just suggest to make the title more precise to avoid any misleading claims.

2. Quantification of changes in Btg1 expression

Changes in Btg1 expression levels are difficult to quantify using WISH, it would be better to use qPCR as orthogonal approach, which could be used to examine the reduction in the context of both the homozygote and heterozygous animals.

3. Mechanism of Btg1 repression

One alternative to the hypothesis that Btg1 expression is downregulated due to the topological isolation of a putative enhancer is proximity spreading of a repressive mark such as H3K27me3. Indeed, the authors have previously shown that this region insertion is heavily decorated in Polycomb marks in its native context (Rodriguez-Carballo et al., 2019 – Figure 3). I think that this is an important conceptual distinction (linear spreading vs disruption of 3D landscape) and resolving it may enhance the conceptual novelty of the paper. H3K27me3 ChIP-seq in the Tg vs WT would resolve this question.

Minor Points:

- Please add mapping and QC stats for the Hi-C/4C experiments to better estimate the resolution

- Figure1: It would be great to also add the insulation score (similar to Figure4) to quantitatively show the loss of insulation upon deletion

- Figure3: Please show the CTCF ChIP signal in an unrelated control region (wt vs TgN(38-40), to ensure that the difference in intensity is indeed due to the presence of the extra CS38 site

- Figure4: it would be great to also show the H3K27ac ChIP-seq signal at the integration locus, in order to visualize the putative enhancer (instead of just mentioning it in the discussion).

- Showing the insulation score in Fig 4 as an overlay between WT and the Tg line would make the comparison much easier for the reader.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Daniel Ibrahim

Reviewer #3: No

Decision Letter 1

Gregory S Barsh, Stefan Mundlos

30 Jun 2021

Dear Dr Duboule,

We are pleased to inform you that your manuscript entitled "INDUCTION OF A CHROMATIN BOUNDARY IN VIVO UPON INSERTION OF A TAD BORDER" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Stefan Mundlos

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #2: The authors have adressed all reviewer comments and I support publication of the manuscript.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Daniel Ibrahim

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-00201R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory S Barsh, Stefan Mundlos

14 Jul 2021

PGENETICS-D-21-00201R1

INDUCTION OF A CHROMATIN BOUNDARY IN VIVO UPON INSERTION OF A TAD BORDER

Dear Dr Duboule,

We are pleased to inform you that your manuscript entitled "INDUCTION OF A CHROMATIN BOUNDARY IN VIVO UPON INSERTION OF A TAD BORDER" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Initial characterization of the TgN(38–40) mutant configuration by TLA (related to Fig 2).

    (A) TLA signal mapped over all mm10 chromosomes (y-axis data range: 0–5000). Green arrowhead indicates region CS38-40, which composes the transgene, in chromosome 2. Brown arrowhead highlights the integration site in chromosome 10. Asterisk shows an artefactual peak of signal matching a satellite repeat. (B) TLA signal over the fosmid sequence. Below, fosmid scheme. (C) Assessment of all three different possible tandem configurations: tail-to-head, tail-to-tail and head-to-head. Coverage (top) and individual reads (bottom) supporting or dismissing each configuration. Candidate tandem connections are highlighted by a red dotted line. All data displayed in this figure were obtained using the vector viewpoint and correspond to the end-to-end coverage.

    (EPS)

    S2 Fig. Transgene quantifications using qPCR and Control-FREEC (related to Fig 2).

    (A) qPCR of samples that were either wild-type (blue circles), heterozygous for the deletion of the endogenous region CS38-40 in chromosome 2 (del(CS38-40)+/-, green squares), or hemizygous for the integration (TgN(38–40)/Wt, red triangles). Transgene targets: CS38, CS39 and CS40a; control target: Hoxd8d9. Vertical axis reflects absolute allele counts. Means are indicated by solid black bars and values are shown above. (B) Control-FREEC transgene quantification using non-overlapping windows (w) of size 1 or 2 kb. Both (test/control)·2 signal ratio and copy numbers estimations (copy #) are shown along region CS38-40 (mm10 coordinates). The copy # signal represents absolute allele counts and the values are indicated in white within the corresponding tracks. Bottom, extension of the TgN(38–40) construct and del(CS38-40) background. In both panels, red and yellow lines indicate expected values for one and a half or two and a half fosmid copies, respectively.

    (EPS)

    S3 Fig. Base-pair map of the TgN(38–40) mutant genome (related to Fig 2).

    (A) TLA reanalysis revealing left and right integration breakpoints (red and green arrows, respectively). The region displayed (mm10, chr10:97019018–97020046) is centered around the validated integration site (mm10, chr10:97019222–97019824). Both end-to-end and CATG-split unmapped coverages are shown. TLA restriction sites are shown at the bottom of the panel. (B) Schematic reconstruction of the TgN(38–40) integration. (C) Connections between chromosome 10 and the construct (left breakpoint, red; right breakpoint, green). Sequences are color-coded and/or underlined according to their origin. All identified connections were found in such a sequence configuration that the Watson strands of the transgene (tg) and chromosome 10 were fused. The asterisk indicates the limits of the 602 bp duplication.

    (EPS)

    S4 Fig

    ChIP of CTCF in several control loci at (A) chromosome 1, (B) chromosome 8 and (C) chromosome 19 (related to Fig 3). Dashed horizontal lines are displayed for indirect comparison with CTCF binding at region CS38-40 (see Materials and Methods).

    (EPS)

    S5 Fig. Frequency of interactions and genomic distances (related to Fig 4).

    (A) Logarithmic relationship between interaction probability and increasing genomic distances computed from the Hi-C data of wild-type limbs. These calculations were applied genome-wide, to an aggregate of all TADs in the genome and to individual TADs including the Btg1 TAD at chromosome 10 and six other TADs in the same chromosome. Values of alpha and R-value are shown for each condition. (B) Hi-C map depicting TADs 1–8 analyzed in (A).

    (EPS)

    S6 Fig. Global Btg1 expression changes upon reorganization of the host chromatin landscape (related to Figs 3 and 4).

    (A) Btg1 WISH in wild-type and TgN(38–40) mutant embryos at E9.5. Heads were partially severed and used for genotyping. Arrowheads point to the area where the presumptive limb bud is located. Scale bar: 500 μm. (B) Btg1 WISH in wild-type and TgN(38–40) homozygous embryos at E12.5. LPM: Lateral plate mesoderm. FM/WP: Facial mesenchyme and whisker pads. Scale bar: 1 mm. (C) Magnified pictures of mammary buds for the same embryos as in panel B. The position of the forelimbs, which were removed for easier mammary bud visualization, is highlighted by a dotted line. Scale bar: 300 μm. The proportion of embryos displaying equivalent patterns in each experiment is shown. Empty arrowheads indicate changes in expression compared to bold arrowheads.

    (TIF)

    S1 Table. Identification of topological boundaries using various window sizes.

    Source data (for different genotypes and mapped genomes) and TAD calling window sizes (w) are indicated. At the HoxD locus, Atf2 is the left boundary of the C-DOM and Hnrnpa3 is the right boundary of the T-DOM. Left_Bd and Right_Bd are respectively the left and right boundaries of the TAD hosting the TgN(38–40) construct in chromosome 10 (see Figs 3B and 4A).

    (DOCX)

    S2 Table. List of TLA, qPCR, 4C-seq and RT-qPCR primers used in this study.

    For the 4C-seq primers, Illumina Solexa sequencing adapters are indicated in red (long adapter) or blue (short adapter). For both CS38 and CS40 viewpoints, a 4 bp barcode (underlined) was present between the long sequencing adapter and the rest of the primer. F: forward. R: reverse. iF: inverse forward. iR: inverse reverse.

    (DOCX)

    S3 Table. EnGen-compatible DNA oligos used as templates for sgRNA production.

    The name of the oligos indicates their approximate position on the TgN(38–40) transgene or surrounding regions: upstream of the transgene in chr 10 (up); one quarter (1/4), halfway (1/2) or three quarters (3/4) into the transgene; 3’ part of transgene vector (pEpi3) and downstream of the transgene in chr10 (down). Two pairs of primers (1 or 2) were design to target the same region. Underlined, sequence matching target DNA. Red, sequence of the T7 promoter for sgRNA production. Cyan, RNA scaffold for the Cas9 enzyme. A G was added (highlighted in black) when not present in the original target sequence, to ensure efficient sgRNA transcription.

    (DOCX)

    S4 Table. Summary of the MinION sequencing output.

    Target reads are reads mapping to the construct or the integration site. Construct coordinates taken into consideration: chr2:75123000–75160000 (mm10). Considered integration site: chr10:97018700–97019300 (mm10). *Ratio of bases of the mutant construction (64,420 bp; see Fig 2D) relative to the haploid mouse genome (around 2.6 Gb): 2.457384e-05.

    (DOCX)

    S5 Table. Summary of the Hi-C sequencing output.

    Two samples were sequenced: TgN3840 (mutant) and Wt (control). Both were subsequently mapped either on mm10 wild-type mouse genome or the custom TgN(38–40) genome. Total reads correspond to all raw reads obtained from the sequencing platform. Cis-far reads correspond to intra-chromosomal interactions located further than 10 kb. All sequencing outputs are shown as base pairs (bp).

    (DOCX)

    S6 Table. Summary of mapped reads from 4C-seq experiments.

    (DOCX)

    S7 Table. Summary of 4C-seq fragment distribution.

    (DOCX)

    S8 Table. Biological replicates of the ChIP-seq and ChIPmentation (ChIPm) experiments.

    Wild-type ChIP-seq data of CTCF, RAD21, and H3K27ac were retrieved from a previous publication of our group (see Data availability). WL: whole limbs. DFL: distal forelimbs.

    (DOCX)

    S9 Table. Genotypes of 4C-seq and Hi-C samples.

    Genotypes of 4C-seq samples are colored in the same way than the corresponding tracks of Fig 3. WL: whole limbs (including both forelimbs and hindlimbs).

    (DOCX)

    S10 Table. Spreadsheets of Ct values coming from the RT-qPCR experiments done in limbs and livers from wild-type and hemizygous embryos (TgN(38–40)/Wt).

    (XLSX)

    Attachment

    Submitted filename: Willemin_2021_PLoS_Genetics_response_to_referees_20210609.docx

    Data Availability Statement

    All datasets produced in this study were deposited in the Gene Expression Omnibus (GEO) under the accession number GSE166584.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES